Canada approves Moderna’s RSV vaccine, first of its kind for older adults – National
Descrease article font size Increase article font size Moderna said on Friday that Canada’s health regulator has approved its vaccine for respiratory syncytial virus (RSV) in adults 60 years and older, making it the country’s first authorized mRNA-based shot for the condition. Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory…